Skip to main content
. 2011 Dec 29;16(1):142–151. doi: 10.1111/j.1582-4934.2011.01292.x

Fig 4.

Fig 4

Morphological changes in CP-treated LoVo cells. (A) Phase-contrast micropho-tographs (100×) of control (a) or treated for 24 hrs with IC50 of CP (a′) LoVo cells. (B) TEM analysis of control (b), or CP-treated LoVo cells for 12 hrs (b′) or 24 hrs (b″ and b‴). (C) Calnexin staining of control LoVo cells (c) or exposed to CP for 12 hrs (c′).